Member Info for PL75

Neut, that hopefully is the beauty of AVA6k. Delivery of a well known drug rather than developing a new one and as opined on the science day if It Works (tm), it captures the market. Suggests a higher CoS and a higher chance of dominance.

Hi RAH, is this the reference you're using? https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409418/

Can't fault the sums, but it defines the potential. Given the concept is being proven, at some point the value gap will close - either sharply via a takeover or over time via funded strategy by licensing / Nasdaq. If you believe in what they're doing, the gap is frustrating but also presents an opportunity. Make hay whilst the sun shines with 'top ups' until 'mid summer'.

gje - really pleased to see the reintroduction of lists of posters. I'd like to apply to be on the ramping, FUDsters and the never vanished crew please. It just wouldn't be a list without my name on there.

Literally bashing. Clearly targeted. It’s not ‘concerned’ investors. The relentless daily spamming from numerous accounts demonstrates that. If you were genuinely concerned to anywhere near that constant extent you’d sell, shove your fiver under your mattress, straighten up your tin hat and get back to counting your cans in your bunker. Anyone could choose a share at random, spend 2 mins reading a couple of RNSs and then gormlessly ask utterly pointless FUD questions about future unknowns. It isn’t at random though, it’s a popular retail share which is why on a day like today when literally nothing is happening with the business, this board will be near the top of the chat boards. Full of spam and people making the mistake of replying. Incredibly tiresome, but it’s the nature of this cesspit. It’s just something genuine holders and investors have to suffer. Ah well.

Have fun today, shall I kick off…. When will Apicell be commercialised? I’m concerned it will take years and in future funding rounds our share will be diluted to such an extent it’s effectively taking up energy from the main business and will cost us money.

I thought it was a stupid suggestion so we’re quits. If they’d come out grinning and chucking out superlatives they’d have been criticised for ramping. They’re scientists mid trial and I thought their their matter of fact delivery was spot on

Absolutely. I was disappointed not to see Fiona in a rara skirt throwing shapes with her pom poms. FML…

That sounds easy rather than difficult as there’s plenty cash to get the point the data demonstrates It works (tm) which should encourage a licence or buyout. Without one, his piece in the paper suggests that Nasdaq awaits. He moved at a sensible time for the latest finance deal and threw in a cash generating business. I’m sure there’s a plan B.

Amazing. I’m not sure we need someone with filet o fish stains down their front to educate us that a bigger number is bigger than a smaller number.

Separate threads having a pop at Myles and Alan. Anyone else retching from the hideous eggy stench of sulphur? DTW, spot on again. Couldn’t care less about the market reaction to the science day and couldn’t care less about anyone else’s decisions. Seems someone is bitter. Another failed gamble no doubt. Ah well.

Bein, you mentioned that line last night also. Can you expand your thoughts? Isn’t a safer version that delivers equivalent dox an instantly marketable winning product? (Once trialled properly)

Suggest switching off again. Still no idea why people bite when it’s so obviously gormless twattery. Meanwhile there’s a useful thread continuing…

Only one thing for it, start another cycle, all aboard the next hype train… Choo Choo! Next stop AACR, less than 50 sleeps!

Do exactly that, switch off. We’ve seen it before, an army of one post wonders, all spouting doom. It’s not worth any engagement as it’s nonsense and it’s also what they want. We’re the top chat board, great if it was some worthwhile discussion on the content of the presentations. Unfortunately it’s a popular retail share and therefore a target for this kind of rubbish. Speaking of which, they’ll have a target in mind - some twat called Elliot probably decided it. Let them make a few quid. Best bet is not respond to any previously silent suddenly concerned long term holders. There’s been some great discussions on the SD, it’s a shame it so easily and quickly descends when the market is open. There’ll always be a new angle, placing on the way (nope), does it work (unequivocally), now it’s the awful misery of a clinical trial taking some additional time because it’s hugely successful - what a tragedy. If an opportunity presents itself, take it, maybe time for another ‘top up’.

He probably overheard it in maccies. Anyway, thanks JT, great thread

Spot on DTW, thanks for cutting through the nonsense. Couldn’t have summarised it better. It works (tm), they have plenty cash and have proven they have the ability to raise more if needed.

I thought the opposite Timster, I enjoyed watching the scientists in their natural habitat discussing everything in a very straightforward manner. Such clarity and realism in RNSs would stop the analysing of every word.

‘I can only suppose they were expecting some kind of real benefit and maybe the pep talk they were given on expressing interest was actually very positive‘

Whereas I can suppose they’re very ill end of life patients doing something truly altruistic. Pep talk raising expectations? Yeah, I’m sure that’s how it works. Vile cretin.

Given that, the discussions on changing the protocol due to the lifetime limit of dox are moot? As it’s working so well we’ll be nowhere the limits.

Well I for one am disappointed by the 1.5 day wait. I just wanted to express that.

Use reply

There is, for very good reason Toaster. Got to be better than stopping it as it doesn’t work, but nice try FUDster. As it progresses, so does the pipeline and the value / takeover cost grows.